Macrogenics Inc (MGNX)
15.49
-0.06
(-0.39%)
USD |
NASDAQ |
May 02, 11:53
Macrogenics Revenue (Quarterly): 9.164M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.164M |
| September 30, 2023 | 10.40M |
| June 30, 2023 | 13.14M |
| March 31, 2023 | 24.21M |
| December 31, 2022 | 71.18M |
| September 30, 2022 | 41.73M |
| June 30, 2022 | 26.01M |
| March 31, 2022 | 10.67M |
| December 31, 2021 | 12.34M |
| September 30, 2021 | 15.66M |
| June 30, 2021 | 30.76M |
| March 31, 2021 | 16.07M |
| December 31, 2020 | 51.75M |
| September 30, 2020 | 17.42M |
| June 30, 2020 | 15.64M |
| March 31, 2020 | 12.97M |
| December 31, 2019 | 24.56M |
| September 30, 2019 | 17.98M |
| June 30, 2019 | 9.987M |
| March 31, 2019 | 9.497M |
| December 31, 2018 | 14.97M |
| September 30, 2018 | 20.62M |
| June 30, 2018 | 18.55M |
| Date | Value |
|---|---|
| March 31, 2018 | 4.501M |
| December 31, 2017 | 152.08M |
| September 30, 2017 | 1.076M |
| June 30, 2017 | 1.081M |
| March 31, 2017 | 1.278M |
| December 31, 2016 | 9.476M |
| September 30, 2016 | 2.014M |
| June 30, 2016 | 78.50M |
| March 31, 2016 | 1.893M |
| December 31, 2015 | 9.41M |
| September 30, 2015 | 14.68M |
| June 30, 2015 | 5.598M |
| March 31, 2015 | 71.16M |
| December 31, 2014 | 5.911M |
| September 30, 2014 | 18.28M |
| June 30, 2014 | 9.202M |
| March 31, 2014 | 14.40M |
| December 31, 2013 | 16.02M |
| September 30, 2013 | 20.11M |
| June 30, 2013 | 11.84M |
| March 31, 2013 | 10.07M |
| December 31, 2012 | 9.362M |
| September 30, 2012 | 15.53M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
9.164M
Minimum
Dec 2023
71.18M
Maximum
Dec 2022
22.72M
Average
16.07M
Median
Mar 2021
Revenue (Quarterly) Benchmarks
| Allurion Technologies Inc | 8.235M |
| United Therapeutics Corp | 614.70M |
| MEI Pharma Inc | -- |
| Marinus Pharmaceuticals Inc | 7.19M |
| Voyager Therapeutics Inc | 90.06M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -46.07M |
| Total Expenses (Quarterly) | 58.52M |
| EPS Diluted (Quarterly) | -0.75 |
| Enterprise Value | 741.01M |
| Gross Profit Margin (Quarterly) | 98.22% |
| Profit Margin (Quarterly) | -502.7% |
| Earnings Yield | -1.03% |
| Normalized Earnings Yield | -13.40 |